Citius Pharmaceuticals, Inc. — Balance Sheet Charts
62 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+16.3% +$20M
$140M
Current Assets↑+107.0% +$20M
$38M
Cash & Equivalents↑+601.9% +$7M
$8M
Receivables
$4M
Inventory↑+57.4% +$8M
$23M
Net PPE↓-89.6% -$2K
$275
Goodwill↑+0.0% +$0
$9M
Total Liabilities↓-9.4% -$5M
$47M
Current Liabilities↓-14.7% -$7M
$38M
Account Payables↑+49.7% +$4M
$11M
Stockholders Equity↑+16.0% +$11M
$80M
Retained Earnings↓-17.0% -$36M
$-247M
Operating Lease ROU Asset↑+336.3% +$644K
$835K
Operating Lease Liability↑+305.6% +$625K
$830K
Gross PP&E↑+24.9% +$2K
$11K
Accumulated Depreciation↑+31.4% +$2K
$9K
Inventory WIP↓-15.7% -$1M
$7M
Inventory Finished Goods↑+155.7% +$10M
$16M
Total Debt Carrying Amount
$600K